Published online February 1, 2008
PEDIATRICS Vol. 121 No. 2 February 2008, pp. 289-296 (doi:10.1542/10.1542/peds.2007-1103)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, B. H.
Related Collections
Right arrow Office Practice
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants Exposed Prenatally to Dexamethasone Versus Betamethasone

Ben H. Lee, MD, MPH, MSCRa,b, Barbara J. Stoll, MDa, Scott A. McDonald, BSc, Rosemary D. Higgins, MDd for the National Institute of Child Health and Human Development Neonatal Research Network

a Division of Neonatal-Perinatal Medicine, Emory University School of Medicine, Atlanta, Georgia
b MidAtlantic Neonatology Associates, Morristown, New Jersey
c Research Triangle Institute, Research Triangle Park, North Carolina
d National Institute of Child Health and Human Development, Washington, DC

OBJECTIVE. We compared the development of adverse neurodevelopmental outcomes at corrected ages of 18 to 22 months for extremely low birth weight infants exposed prenatally to dexamethasone, betamethasone, or no steroid.

METHODS. Study infants were extremely low birth weight (401–1000 g) infants who were in the care of National Institute of Child Health and Human Development Neonatal Research Network centers between January 1, 2002, and April 30, 2003; they were assessed neurodevelopmentally at corrected ages of 18 to 22 months. Outcomes were defined as Bayley Scales of Infant Development-II Mental Development Index of <70, Bayley Scales of Infant Development-II Psychomotor Development Index of <70, bilateral blindness, bilateral hearing aid use, cerebral palsy, and neurodevelopmental impairment. Neurodevelopmental impairment was defined as ≥1 of the aforementioned outcomes.

RESULTS. A total of 1124 infants met entry criteria. There were no statistically significant associations between prenatal dexamethasone exposure and any follow-up outcome, compared with no prenatal steroid exposure. Prenatal betamethasone exposure was associated with reduced risks of hearing impairment and neurodevelopmental impairment and with increased likelihood of unimpaired status, compared with no prenatal steroid exposure. Compared with betamethasone, dexamethasone was associated with a trend for increased risk of Psychomotor Development Index of <70, increased risk of hearing impairment, and decreased likelihood of unimpaired status.

CONCLUSIONS. Prenatal betamethasone exposure was associated with increased likelihood of unimpaired neurodevelopmental status and reduced risk of hearing impairment at corrected ages of 18 to 22 months among extremely low birth weight infants, compared with prenatal dexamethasone exposure or no prenatal steroid exposure. Pending a randomized, clinical trial, it may be in the best interests of infants to receive betamethasone, rather than dexamethasone, when possible.

Key Words: prenatal glucocorticoid treatment • dexamethasone • betamethasone • extremely low birth weight • neurodevelopmental outcome

Abbreviations: BSID-II—Bayley Scales of Infant Development-II • CP—cerebral palsy • ELBW—extremely low birth weight • MDI—Mental Development Index • NICHD—National Institute of Child Health and Human Development • NDI—neurodevelopmental impairment • PDI—Psychomotor Development Index • PVL—periventricular leukomalacia • PDA—patent ductus arteriosus • CLD—chronic lung disease • ROP—retinopathy of prematurity • OR—odds ratio • CI—confidence interval • EGA—estimated gestational age • IVH—intraventricular hemorrhage

Accepted Jul 23, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
N. E. Schlabritz-Loutsevitch, J. C. Lopez-Alvarenga, A. G. Comuzzie, M. M. Miller, S. P. Ford, C. Li, G. B. Hubbard, R. J. Ferry Jr, and P. W. Nathanielsz
The Prolonged Effect of Repeated Maternal Glucocorticoid Exposure on the Maternal and Fetal Leptin/Insulin-like Growth Factor Axis in Papio species
Reproductive Sciences, March 1, 2009; 16(3): 308 - 319.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. L. Gatford, J. A. Owens, S. Li, T. J. M. Moss, J. P. Newnham, J. R. G. Challis, and D. M. Sloboda
Repeated betamethasone treatment of pregnant sheep programs persistent reductions in circulating IGF-I and IGF-binding proteins in progeny
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E170 - E178.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. Brucato
Prevention of congenital heart block in children of SSA-positive mothers
Rheumatology, June 1, 2008; 47(suppl_3): iii35 - iii37.
[Abstract] [Full Text] [PDF]

Home page
 JWatch PediatricsHome page
Steroids for Women in Premature Labor and Infant Outcomes
Journal Watch Pediatrics and Adolescent Medicine, February 27, 2008; 2008(227): 1 - 1.
[Full Text]